Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Shares Outstanding (2021 - 2025)

PAVmed has reported Shares Outstanding over the past 5 years, most recently at $927934.0 for Q4 2025.

  • Quarterly results put Shares Outstanding at $927934.0 for Q4 2025, up 148.58% from a year ago — trailing twelve months through Dec 2025 was $927934.0 (up 148.58% YoY), and the annual figure for FY2025 was $927934.0, up 148.58%.
  • Shares Outstanding for Q4 2025 was $927934.0 at PAVmed, down from $1.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PAVM hit a ceiling of $87.0 million in Q2 2022 and a floor of $22511.0 in Q1 2025.
  • Median Shares Outstanding over the past 5 years was $5.8 million (2021), compared with a mean of $21.6 million.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 7239.49% in 2022 and later tumbled 98.56% in 2023.
  • PAVmed's Shares Outstanding stood at $5.8 million in 2021, then grew by 9.43% to $6.3 million in 2022, then plummeted by 79.28% to $1.3 million in 2023, then plummeted by 71.4% to $373300.0 in 2024, then soared by 148.58% to $927934.0 in 2025.
  • The last three reported values for Shares Outstanding were $927934.0 (Q4 2025), $23.1 million (Q3 2025), and $20.1 million (Q2 2025) per Business Quant data.